Active Comparator Option clinical trials

Phase 2 Study of Rapcabtagene Autoleucel in Myositis

This study is testing a new cell therapy called rapcabtagene autoleucel for severe inflammatory muscle diseases (myositis). It aims to see if it's safe and helps people whose current treatments aren't working well.